Back

Screening sham mirror-therapy materials using fNIRS: protocol for an acute within-participant randomised crossover mechanistic study

Yang, T.; Wang, Y.; Wei, S.; Bai, D.

2026-08-25 rehabilitation medicine and physical therapy
10.64898/2026.08.23.26361088 medRxiv
Show abstract

Abstract Introduction Selecting an appropriate sham control is a key challenge in trials of mirror therapy, specifically paradigms using mirror visual feedback (MVF), because visually similar control conditions may still elicit mirror-related cortical responses. This protocol describes an acute mechanistic, within-participant fNIRS screening study designed to identify the sham mirror-therapy material condition with the most "neutral" neural signature relative to true MVF during a single exposure. Methods and analysis This is a single-centre, within-participant, randomised crossover study conducted at Wuhan Wuchang Hospital (Wuhan, China). Healthy adults aged 18-35 years will complete four conditions in one visit: C1 true MVF and three prespecified sham-material conditions (C2-C4), with condition order counterbalanced using a Latin-square schedule. fNIRS will be acquired during a standardised grasping task. Online acquisition-time quality control (SCI and CV thresholds) will be applied with prespecified re-acquisition rules. The primary outcome is ROI-level task-evoked change in oxygenated haemoglobin (Delta HbO) within prespecified ROIs (PMC and SM1/M1), estimated primarily using GLM-derived beta estimates. Condition effects will be analysed using linear mixed-effects models with prespecified contrasts and Holm multiplicity adjustment to rank sham conditions by a prespecified neutrality decision rule. Ethics and dissemination Ethics approval was obtained from the Ethics Committee of Wuchang Hospital Affiliated to Wuhan University of Science and Technology (Approval No.: 2025-112-01). Findings will be disseminated through publication of this protocol manuscript and a subsequent results manuscript, with key supplementary materials provided as online appendices/supplements as required by the target journal. Trial registration number Chinese Clinical Trial Registry: ChiCTR2600116634. Strengths and limitations of this study - Within-participant randomised crossover design reduces between-participant variability and is well suited for acute mechanistic screening of sham conditions. - Prespecified sham conditions and neutral-ranking decision rule, including prespecified ROIs, contrasts, and Holm multiplicity control, help limit analytic flexibility and support transparent interpretation. - Operational reproducibility safeguards are specified, including standardised task timing/instructions, acquisition-time QC thresholds with re-acquisition rules, and frozen channel-to-ROI mapping and material-definition records in the Supplementary materials. - Single-centre, healthy-participant, single-session paradigm may limit generalisability to clinical stroke populations and to longer-term therapeutic effects. - Blinding may be imperfect because perceptual differences between materials can affect expectancy and attention; blinding assessment is included but residual bias is possible. - fNIRS is susceptible to motion, scalp-coupling variability and physiological noise; despite prespecified QC and preprocessing, residual artefacts may remain and can reduce sensitivity.

Matching journals

The top 6 journals account for 50% of the predicted probability mass.

50% of probability mass above

"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.